Melatonin decreases apoptosis and expression of apoptosis-associated proteins in acute puromycin aminonucleoside nephrosis
Author(s) -
Adriana Pedreáñez,
J. Rincón,
Maritza J. Romero,
Ninoska T. Viera,
Jesús Mosquera
Publication year - 2004
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfh068
Subject(s) - nephrosis , apoptosis , endocrinology , medicine , malondialdehyde , fas ligand , puromycin , lipid peroxidation , superoxide dismutase , oxidative stress , melatonin , tunel assay , biology , microbiology and biotechnology , biochemistry , programmed cell death , protein biosynthesis
The anti-apoptotic properties of melatonin have been demonstrated previously in several in vivo and in vitro studies. Previous reports have shown increased apoptosis during puromycin aminonucleoside nephrosis (PAN). The aim of this study was to determine if melatonin (MEL) can prevent apoptosis and modify oxidative stress, an apoptosis inducer, in this experimental model.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom